Photo from Memorial Sloan Kettering Radiation Oncology/X
Apr 8, 2024, 12:28
Memorial Sloan Kettering Radiation Oncology – Phase II trial shows the rate of implant failure in reconstructed patients with breast cancer
Memorial Sloan Kettering Radiation Oncology shared on X:
“New in International Journal of Radiation Oncology, Biology, Physics: Phase II trial shows the rate of implant failure in reconstructed patients with breast cancer treated with IMRT was similar to, but not improved over, conventional, 3D-conformal radiation. Breast cancer serial MRIs may detect early capsular contracture.”
Proceed to the article.
Source: Memorial Sloan Kettering Radiation Oncology/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 22, 2025, 02:57
Aug 22, 2025, 02:54
Aug 22, 2025, 02:49
Aug 21, 2025, 23:33
Aug 21, 2025, 20:00
Aug 21, 2025, 15:59